Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Hualu Biotechnology (300970) Specific Shareholder Suqian Huaxin Proposes to Reduce Holdings of No More Than 1.872 Million Shares, Accounting for 1.56% of Total Share Capital
Jiangsu Hualu Biological Technology Group Co., Ltd. (hereinafter referred to as “Hualu Biology” or “the Company”) announced on March 17, 2026, that its specific shareholder, Suqian Huaxin Investment Management Center (Limited Partnership) (hereinafter referred to as “Suqian Huaxin”), plans to reduce its holdings of the Company’s shares through centralized bidding within the next three months. The reduction will not exceed 1,872,000 shares, accounting for 1.56% of the total share capital after excluding the repurchased shares.
Shareholder Basic Information
According to the announcement, Suqian Huaxin currently holds 1,872,000 shares of Hualu Biology before its initial public offering. As of the announcement date, the total share capital of the Company is 122,609,100 shares, minus 2,346,600 shares repurchased, leaving a remaining total of 120,262,500 shares. Suqian Huaxin’s shareholding ratio is 1.56%.
Core Content of the Reduction Plan
Scale and Method of Reduction
Suqian Huaxin intends to reduce no more than 1,872,000 shares, which represents all of its holdings. The reduction will be conducted through centralized bidding transactions. Within any consecutive 90 calendar days, the total shares reduced via centralized bidding will not exceed 1% of the total share capital after excluding the repurchased shares.
Period and Price of Reduction
The reduction period is from 15 trading days after this announcement until three months later, i.e., from April 9, 2026, to July 8, 2026. The reduction price will be determined based on the market price at that time.
Reason for Reduction
The announcement clearly states that Suqian Huaxin’s reduction is due to “the shareholder’s own capital needs.”
Shareholder Commitment and Performance
According to the prospectus and listing announcement at the time of Hualu Biology’s initial public offering, Suqian Huaxin made several commitments:
As of the announcement date, Suqian Huaxin has strictly fulfilled these commitments without any violations. The current reduction plan is consistent with previously disclosed intentions and commitments.
Risk Warning and Impact Analysis
The announcement indicates that Suqian Huaxin will decide whether to implement the reduction plan based on market conditions, the company’s stock price, and other factors. Therefore, the timing, quantity, and price of the reduction are uncertain. However, Suqian Huaxin is not a controlling shareholder, actual controller, or a person acting in concert with them, so this reduction will not lead to a change in the company’s control or significantly impact corporate governance and ongoing operations.
Additionally, the company emphasizes that this reduction plan does not violate the “Interim Measures for the Management of Shareholder Reductions in Listed Companies,” “Guidelines for Self-Regulation of Listed Companies on the Shenzhen Stock Exchange No. 18—Shareholders, Directors, and Senior Management Shareholding Reductions,” or other relevant regulations. The company also states that there are no issues such as share price falling below issuance price, net asset value, or dividend distribution problems that would restrict controlling shareholders from reducing their holdings.
The company will disclose the progress of the reduction plan in a timely manner according to relevant regulations. Investors are advised to make cautious decisions and be aware of investment risks.
Disclaimer: The market involves risks; investments should be cautious. This article is automatically published by an AI model based on third-party databases and does not represent Sina Finance’s views. All information herein is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for details. For questions, contact biz@staff.sina.com.cn.
Click here to view the original announcement>>